DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

C.R. Bard, Inc. (NYSE: BCR)

156.97 2.74 (1.78%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BCR $156.97 1.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $155.10
Previous Close $154.23
Daily Range $155.10 - $157.84
52-Week Range $125.00 - $157.84
Market Cap $11.7B
P/E Ratio 15.18
Dividend (Yield) $0.88 (0.6%)
Ex-Dividend Date
Dividend Pay Date
10/16/14
10/31/14
Volume 759,018
Average Daily Volume 563,903
Current FY EPS $8.31

Sector

Healthcare

Industry

Healthcare Information Services

C.R. Bard, Inc. (BCR) Description

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Website: http://www.crbard.com/

News & Commentary

A Smart Move for Endo International?

Endo International PLC management continues to build value through acquisitions

CR Bard Beats Q3 Earnings and Revenues, '14 View Raised - Analyst Blog

C. R. Bard's (BCR) CEO Timothy Ring on Q3 2014 Results - Earnings Call Transcript

C. R. Bard (BCR) Q3 2014 Results - Earnings Call Webcast

Dividend Aristocrats In Focus Part 19 Of 54: C.R. Bard

Is CR Bard (BCR) Poised to Beat Earnings This Season? - Analyst Blog

Dividend Aristocrats In Focus Part 19 of 54: CR Bard

Dividend Aristocrats In Focus Part 19 of 54: CR Bard

C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for October 16, 2014

CR Bard's Lutonix 035: First FDA-Approved DCB in the US - Analyst Blog

Royal Bank Of Canada Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More

The Lutonix® 035 Drug Coated Balloon Is The First And Only FDA-Approved DCB Available In The U.S. Fo

The Lutonix® 035 Drug Coated Balloon Is The First And Only FDA-Approved DCB Available In The U.S. For The Treatment Of Femoropopliteal Occlusive Disease

See More BCR News...

BCR's Top Competitors

BCR $156.97 (1.78%)
Current stock: BCR
$0.00 (0.00%)
Current stock:
MDT $66.56 (1.45%)
Current stock: MDT
COV $89.64 (1.35%)
Current stock: COV